-
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Impact on stimulant use and 12-step engagement.
Donovan DM. Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Impact on stimulant use and 12-step engagement. Presented at the College on Problems of Drug Dependence annual meeting, Palm Springs, CA, June 9-14, 2012.
-
Evaluating a culturally adapted version of Real Men Are Safe.
Calsyn DA. Evaluating a culturally adapted version of Real Men Are Safe. Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 9-14, 2012.
-
Including prisoners in substance abuse clinical trials.
Campbell ANC. Including prisoners in substance abuse clinical trials. Presented at the Society for Clinical Trials annual meeting, Miami, FL, May 20-23, 2012.
-
Turnover and the substance abuse treatment workforce: Results from Project MERITS.
Eby LT. Turnover and the substance abuse treatment workforce: Results from Project MERITS. Presented at the CTN Steering Committee Meeting, Atlanta, GA, April 17-18, 2012.
-
Advances in clinical research for prescription opioid dependence.
Provost SE, Potter JS, Weiss RD. Advances in clinical research for prescription opioid dependence. Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
-
HIV prevention in community-based substance abuse treatment: The NIDA CTN Safer Sex Skills Building Study for Women.
Campbell ANC. HIV prevention in community-based substance abuse treatment: The NIDA CTN Safer Sex Skills Building Study for Women. Presented at the Annual Meeting of the Society for Social Work and Research, Washington, DC, January 11-15, 2012.
-
NIDA’s Clinical Trials Network: A source of social work practice-relevant knowledge.
Wells EA, Daley DC. NIDA's Clinical Trials Network: A source of social work practice-relevant knowledge. Presented at the Annual Meeting of the Society for Social Work and Research, Washington, DC, January 11-15, 2012.
-
Community-based clinical trials: Site variation and adoption of innovation.
McCarty D, Buti A, Kunkel LE, Fussell HE, Eakins D, Straus MM. Community-based clinical trials: Site variation and adoption of innovation. Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011
-
Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START).
Ling W, Saxon AJ. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011
-
12-step facilitation: New evidence from the National Drug Abuse Clinical Trials Network.
Donovan DM, Daley DC. 12-step facilitation: New evidence from the National Drug Abuse Clinical Trials Network. Presented at the American Academy of Addiction Psychiatry (AAAP) annual meeting, Scottsdale, AZ, December 8-11, 2011